Merger Announcement
CopilotIQ and Biofourmis merge to create the first
end-to-end platform for AI-driven in-home care.
Connecting solutions to step up care
Biofourmis addresses challenges impacting the health and pharmaceutical industries today across the continuum from drug development to care delivery. By delivering and transitioning patients across levels of care, clinical trials, and drug companions, our solutions offer patients continuity of care and more care options. Our partners rely on Biofourmis for streamlined services, access to targeted patient populations, and improved economic, operational, and clinical outcomes.
Making home the site of care
Our technology-enabled solutions empower patients to receive care at home, and easily transition between levels and locations of care. Outcomes have shown clinical, operational, and economic improvements such as a 70% reduction in 30-day readmissions, the ability to detect deterioration 21 hours sooner, and reductions in cost of care by up to 38%1,2.
Our collaborators in the healthcare-delivery revolution
News & Insights
1. Un, KC., Wong, CK., Lau, YM. et al. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients. Sci Rep 11, 4388 (2021). https://doi.org/10.1038/s41598-021-82771-7.
2. Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17. PMID: 31842232.
*Subject to geography and connectivity